- $3.14bn
- $3.06bn
- $125.81m
- 24
- 10
- 43
- 14
Annual cashflow statement for HeartFlow, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -95.7 | -96.4 |
| Depreciation | ||
| Non-Cash Items | 19.1 | 28.2 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -7.54 | -8.86 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -76.4 | -69 |
| Capital Expenditures | -6.11 | -4.36 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | -6.11 | -4.36 |
| Financing Cash Flow Items | 0 | -2.33 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 169 | 2.24 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 86.3 | -71.4 |